Cetera Advisor Networks LLC Amarin Corp Plcuk Transaction History

Cetera Advisor Networks LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.82 - $1.35 $245 - $405	-300 Reduced 2.76%	10,555 $9,000
Q4 2023 Feb 13, 2024	SELL	$0.66 - $0.91 $231 - $318	-350 Reduced 3.12%	10,855 $9,000
Q3 2023 Nov 14, 2023	SELL	$0.85 - $1.43 $297 - $500	-350 Reduced 3.03%	11,205 $10,000
Q1 2023 May 15, 2023	BUY	$1.19 - $2.19 $13,750 - $25,305	11,555 New	11,555 $17,000
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $17,169 - $36,603	-4,717 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$4.78 - $8.26 $22,547 - $38,962	4,717 New	4,717 $33,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.